Interleukin 10 production correlates with pathology in human Leishmania donovani infections.
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
We have found that an important Th2 cytokine, IL-10, is produced by tissues from patients acutely infected with Leishmania donovani. In all individuals tested, IL-10 mRNA production was increased in lymph nodes taken during acute disease over that observed in postacute samples. In contrast, both pre- and posttreatment lymph nodes had readily detected mRNA for IFN-gamma and IL-2. A down-regulating effect of IL-10 on leishmania-induced proliferative responses was demonstrated when Hu rIL-10 was added to cultures of PBMC from clinically cured individuals. PBMC from individuals with acute visceral leishmaniasis responded to stimulation with leishmania lysate by producing IL-10 mRNA. Simultaneously cultured PBMC collected from the same patients after successful chemotherapy produced no detectable IL-10 mRNA after leishmania antigen stimulation. Neutralizing anti-IL-10 mAb added to PBMC from patients with acute visceral leishmaniasis markedly increased the proliferative response to leishmania lysate. Finally, we observed mRNA for IL-10 and IFN-gamma concurrently in a lesion from a patient with post-kala-azar dermal leishmaniasis (PKDL). These results indicate the production of IL-10 during L. donovani infection, and suggest a role for this cytokine in the regulation of immune responsiveness during visceral leishmaniasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.915 · Cited by 1,930
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3444 · Cited by 1,865
Heinzel, F. P., Sadick, M. D., Holaday, B. J., Coffman, R. L., & Locksley, R. M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.59 · Cited by 1,454
Cited by
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
Chappuis, F., Sundar, S., Hailu, A., Ghalib, H., Rijal, S., Peeling, R. W., Alvar, J., & Boelaert, M. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1748 · Cited by 1,490
Self-citationHerwaldt, B. L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10178-2 · Cited by 1,229
Type 1/Type 2 Immunity in Infectious Diseases
Spellberg, B., & Edwards, J. E. (2001) · Clinical Infectious Diseases · doi:10.1086/317537 · Cited by 911
Human Leishmaniasis: Clinical, Diagnostic, and Chemotherapeutic Developments in the Last 10 Years
Berman, J. D. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.684 · Cited by 806
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
Lucey, D. R., Clerici, M., & Shearer, G. M. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.532 · Cited by 666
Anderson, C. F., Oukka, M., Kuchroo, V. J., & Sacks, D. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061886 · Cited by 571
The role of IL-10 in promoting disease progression in Leishmaniasis
Kane, M. M., & Mosser, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.1141 · Cited by 514
Zijlstra, E. E., & El-Hassan, A. M. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90218-4 · Cited by 494
Self-citationHalstead, S. B., Mahalingam, S., Marovich, M. A., Ubol, S., & Mosser, D. M. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70166-3 · Cited by 409
Use of Antimony in the Treatment of Leishmaniasis: Current Status and Future Directions
Haldar, A. K., Sen, P., & Roy, S. (2011) · Molecular Biology International · doi:10.4061/2011/571242 · Cited by 408
Interleukin-10 and the pathogenesis of human visceral leishmaniasis
Nylén, S., & Sacks, D. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.07.004 · Cited by 374
Bañuls, A.-L., Hide, M., & Prugnolle, F. (2007) · Advances in Parasitology · doi:10.1016/s0065-308x(06)64001-3 · Cited by 365
Monocyte subpopulations and their differentiation patterns during infection
Strauss-Ayali, D., Conrad, S. M., & Mosser, D. M. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0307191 · Cited by 348
Nylén, S., Maurya, R., Eidsmo, L., Manandhar, K. D., Sundar, S., & Sacks, D. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061141 · Cited by 328
Carrera, L., Gazzinelli, R. T., Badolato, R., Hieny, S., Muller, W., Kuhn, R., & Sacks, D. L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.515 · Cited by 315
Melby, P. C., Chandrasekar, B., Zhao, W., & Coe, J. E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1912 · Cited by 288
Brockman, M. A., Kwon, D. S., Tighe, D. P., Pavlik, D. F., Rosato, P. C., Sela, J., Porichis, F., Le Gall, S., Waring, M. T., Moss, K., et al. (2009) · Blood · doi:10.1182/blood-2008-12-191296 · Cited by 286
Immunopathogenesis of infection with the visceralizing Leishmania species
Wilson, M. E., Jeronimo, S. M. B., & Pearson, R. D. (2005) · Microbial Pathogenesis · doi:10.1016/j.micpath.2004.11.002 · Cited by 281
IL-10 mediates susceptibility toLeishmania donovani infection
Murphy, M. L., Wille, U., Villegas, E. N., Hunter, C. A., & Farrell, J. P. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<2848::aid-immu2848>3.0.co;2-t · Cited by 275
Second-generation vaccines against leishmaniasis
COLER, R., & REED, S. (2005) · Trends in Parasitology · doi:10.1016/j.pt.2005.03.006 · Cited by 266
Self-citationBalancing immunity and pathology in visceral leishmaniasis
Stanley, A. C., & Engwerda, C. R. (2007) · Immunology & Cell Biology · doi:10.1038/sj.icb7100011 · Cited by 254
Immune responses of cattle to African trypanosomes: protective or pathogenic?
Taylor, K. (1998) · International Journal for Parasitology · doi:10.1016/s0020-7519(97)00154-9 · Cited by 121
Interleukin-10 potential benefits and possible risks in clinical infectious diseases
Opal, S. M., Wherry, J. C., & Grint, P. (1998) · Clinical Infectious Diseases · doi:10.1086/515032 · Cited by 114
“This is detrimental in the presence of systemic microbial invasion by intracellular bacterial [107] or parasitic pathogens of this nature [110-112].”
BackgroundCD4+FOXP3+ cells produce IL-10 in the spleens of dogs with visceral leishmaniasis
Silva, K. L. O., de Andrade, M. M. C., Melo, L. M., Perosso, J., Vasconcelos, R. O., Munari, D. P., & Lima, V. M. F. (2014) · Veterinary Parasitology · doi:10.1016/j.vetpar.2014.03.010 · Cited by 21
Bhaumik, S. K., Paul, J., Naskar, K., Karmakar, S., & De, T. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr575 · Cited by 20
Metadata
- Authors
- Ghalib, H. W., Piuvezam, M. R., Skeiky, Y. A., Siddig, M., Hashim, F. A., el-Hassan, A. M., Russo, D. M., & Reed, S. G.
- Venue
- Journal of Clinical Investigation
- Published
- 1993-07-01
- Volume
- 92
- Issue
- 1
- Pages
- 324-329
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2159975458
- Cited by
- 434
- References
- 30
- FWCI
- 23.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.